コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion, history of brain trauma or intracranial vascular malformations).
2 ts a vascular neoplasm, vascular anomaly, or vascular malformation.
3 cular anomaly could be a vascular tumor or a vascular malformation.
4 s were used to examine the cell capacity for vascular malformation.
5 tient 1 was an 8-mo-old girl with voluminous vascular malformation.
6 ut the presumed etiology was an unidentified vascular malformation.
7 p53 plays a direct role in formation of the vascular malformations.
8 d is frequently associated with intracranial vascular malformations.
9 lastoma multiforme and some other tumors and vascular malformations.
10 1), a disease characterised by bleeding from vascular malformations.
11 There were 49 hemangiomas and 38 vascular malformations.
12 re performed in three patients with low-flow vascular malformations.
13 giectasia (HHT1), a disease characterized by vascular malformations.
14 ins were widely patent without thrombosis or vascular malformations.
15 angiomas, consistent with other Sturge-Weber vascular malformations.
16 ECs) acquired mesenchymal markers and caused vascular malformations.
17 ile pericyte differentiation and hemorrhagic vascular malformations.
18 collectively contribute to the prevention of vascular malformations.
19 migration may represent a pathomechanism in vascular malformations.
20 approach for patients with KRAS G12C-related vascular malformations.
21 y or a different mechanism gives rise to the vascular malformations.
22 s in 3D and engineer fine structures such as vascular malformations.
23 predisposing stimuli for the development of vascular malformations.
24 This article focuses on the management of vascular malformations.
25 event in the pathogenesis of HHT-associated vascular malformations.
26 Transplantation of these cells caused vascular malformations.
27 ies into 2 major groups: vascular tumors and vascular malformations.
28 thologies, including brain tumours and brain vascular malformations.
29 ting angiogenic and inflammatory programs in vascular malformations.
30 to our knowledge, have not been described in vascular malformations.
31 nomalies, differentiating high- and low-flow vascular malformations.
32 Tie-2 in blue rubber bleb nevus and sporadic vascular malformations.
33 hways also contribute to atherosclerosis and vascular malformations.
34 d its involvement in two, if not more, human vascular malformations.
35 as (CHs) account for 5% to 12% of all spinal vascular malformations.
36 a potential strategy to treat patients with vascular malformations.
37 tracranial tumors, functional disorders, and vascular malformations.
38 uctive pulmonary disease, cancers, and brain vascular malformations.
39 deficiency or dysfunction is associated with vascular malformations.
40 eds produced CNS-specific hyperproliferative vascular malformations.
41 rment after surgery for epilepsy, tumours or vascular malformations.
42 to oxygen-induced remodeling without causing vascular malformations.
43 yrAkt led to embryonic lethality, edema, and vascular malformations.
44 oplasms, surgeries nearby sinuses and orbit, vascular malformations, acute sinusitis, systemic abnorm
45 s a neurocutaneous disorder characterized by vascular malformations affecting skin, eyes and leptomen
48 n and extracellular matrix, correlating with vascular malformation and increased basement membrane th
51 ORC1 signaling in endothelial cells promotes vascular malformation and suggest that mTORC1 inhibitors
52 cidate the molecular pathogenesis of hepatic vascular malformation and the safety of therapeutics inh
54 genital portosystemic shunts (CPSS) are rare vascular malformations and can be classified into extrah
55 formations represent the most common form of vascular malformations and can cause recurrent bleeding
57 ciency of HIF-1alpha resulted in cardiac and vascular malformations and embryonic lethality at E10.5.
60 ents with HHT associated with severe hepatic vascular malformations and high cardiac output, administ
61 AS G12C inhibitor, in reducing the volume of vascular malformations and improving survival in two mou
64 sed on melanoma; other skin diseases such as vascular malformations and psoriasis have also been exam
66 gnosis and topographical characterization of vascular malformations and tumors of cervicofacial area
67 stem causing hemorrhage-prone multiple lumen vascular malformations and very severe neurological cons
68 ng seizures for LEAT, 74.0% (328 of 443) for vascular malformation, and 71.5% (2108 of 2948) for hipp
69 atic seizures after presentation, ICH due to vascular malformation, and elevated intracranial pressur
70 sy associated neuroepithelial tumour (LEAT), vascular malformation, and hippocampal sclerosis had the
71 cal issues for patients with hemangiomas and vascular malformations, and (4) the elucidation of seque
72 via the ALK5-SMAD2 signaling induces retinal vascular malformations, and have therapeutic values for
73 morrhagic telangiectasia (HHT), severe liver vascular malformations are associated with mutations in
76 ns that underlie the formation of many human vascular malformations are known, the extent to which ab
84 ism analogous to cancer, in which aggressive vascular malformations arise through the loss of vascula
87 ) may represent a hyperplastic response to a vascular malformation, but the precise etiology remains
88 ascular development and to prevent postnatal vascular malformations, but its molecular effectors are
91 me is a progressive overgrowth disorder with vascular malformations caused by mosaic expression of th
92 ral cavernous malformations (CCMs) are human vascular malformations caused by mutations in three gene
94 ngiectasia (HHT) is an inherited disorder of vascular malformations characterized by mucocutaneous te
96 om 26 patients in a cohort of mixed types of vascular malformation, comprising 2 fast-flow and 24 slo
97 r, and its deregulation is associated with a vascular malformation consistent with Klippel-Trenaunay
98 primary outcome was change in the volume of vascular malformations detected on magnetic resonance im
100 coding SMAD4) or BMPR1A, and the latter is a vascular malformation disorder caused by mutations in EN
101 diologists must identify the MRI features of vascular malformations for better diagnosis and classifi
103 or T2-weighted imaging for low-grade tumors, vascular malformations, gliosis after infarction, inflam
104 hin the CPA, including meningiomas, lipomas, vascular malformations, hemangiomas, epidermoid cysts, c
105 potential therapeutic targets against these vascular malformations identified so far, as well as the
107 genesis may contribute to the development of vascular malformation in IUGR, but in vitro these change
108 us malformations (CCMs) are a common type of vascular malformation in the brain that are a major caus
111 beta-catenin transcription activity, reduce vascular malformations in endothelial CCM3-deficient mic
114 lockers are new potential targets to prevent vascular malformations in patients with hereditary hemor
115 MAP2K1 is sufficient for the development of vascular malformations in the brain, ear, and intestines
116 autosomal dominant disease that manifests as vascular malformations in the brain, lung, liver, gastro
117 he Id1-Id3 double knockout mice also display vascular malformations in the forebrain and an absence o
118 atients; mean age, 32.9 years +/- 14.1) with vascular malformations in the head and neck (n = 64), sp
119 rapping around VEGF-producing fibers, and of vascular malformations in the muscle at high levels, did
121 els, defective angiogenic remodeling, severe vascular malformations including arterio-venous malforma
122 nd arteriovenous identities are disrupted in vascular malformations including arteriovenous shunts, t
123 P/LP variants were previously unreported in vascular malformation, including those from HRAS, PIK3CA
125 bral haemorrhage resulting from intracranial vascular malformation, intracranial venous thrombosis, h
126 dothelium-selective Grk2 ablation had marked vascular malformations involving impaired recruitment of
129 umor cells and also seen in two benign human vascular malformations, juvenile angiofibromas and infan
130 cavernous malformation (CCM) is a disease of vascular malformations known to be caused by mutations i
131 ith pCLAs and 72% of participants with other vascular malformations, leading to a new medical therapy
132 redictor for differentiating hemangioma from vascular malformation (likelihood ratio test = 109.8, P
133 nal period and the observational period (all vascular malformations: mean [SD] difference, -0.001 [0.
134 Alk1-conditional deletion resulted in severe vascular malformations mimicking all pathologic features
137 rogenic procedures (n = 14, 16%), congenital vascular malformations (n = 13, 15%), tumor (n = 13, 15%
138 n of both normal retinal anatomy, as well as vascular malformations, nonperfusion, and neovasculariza
139 vent the increase in permeability and retina vascular malformations observed in the absence of Sox17.
140 an exhibiting a systemic vascular phenotype, vascular malformations occur as focal lesions in discret
144 Cerebral Cavernous Malformations (CCMs) are vascular malformations of the central nervous system whi
145 ons (CCMs) are common sporadic and inherited vascular malformations of the central nervous system.
147 deafness, facial weakness, hypoventilation, vascular malformations of the internal carotid arteries
149 ipal lesion as hippocampal sclerosis, tumor, vascular malformation or acquired pathology during early
150 suspicion of neoplasm, bacterial infection, vascular malformation, or thyroid eye disease were exclu
153 ALK1 signaling protects from development of vascular malformations preserving organ-specific endothe
154 other cellular properties in hemangiomas and vascular malformations relevant to vascular development,
155 es provides a state-of-the-art assessment of vascular malformation research at basic, clinical, genet
159 agnosed disorders related to the presence of vascular malformations should undergo periodic follow-up
161 and displayed reduced sprouting, leading to vascular malformations similar to those seen in humans w
163 the cerebral vasculature, such as congenital vascular malformations, stroke and tumors, compromise ne
165 ibromatosis (NF1), nor is it associated with vascular malformations, such as in the recently reported
169 cyte protein of 76 kDa (SLP76) resulted in a vascular malformation that directed blood flow through m
170 Here, we focus on two of the most studied vascular malformations that are induced by deregulation
172 pathological angiogenesis is angiodysplasia, vascular malformations that cause severe gastrointestina
173 ons (CCMs) are common inherited and sporadic vascular malformations that cause strokes and seizures i
175 llary beds, and the formation of hemorrhagic vascular malformations that remain adherent to the menin
177 in turn perpetuates reduced osteogenesis and vascular malformation through direct SSC-endothelial cro
179 ed to endothelial proliferative lesions from vascular malformations to vascular tumors in adult mice.
180 placental anomalies including thrombosis and vascular malformations, together with growth restriction
181 ve therapeutic effects in treating lymphatic vascular malformations, transplantation rejection and, p
182 and miR-155 knock-out in mice causes retinal vascular malformations typical of faulty maturation, mim
183 irming that mucocutaneous and internal organ vascular malformations undergo the same molecular mechan
184 meruloid microvascular proliferations (GMP), vascular malformations (VM), feeding arteries (FA), and
185 usative for autosomal-recessive intraosseous vascular malformation (VMOS) in five different families.
187 HHT) is a Mendelian disease characterized by vascular malformations (VMs) including visceral arteriov
188 festations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors.
191 an adaptor protein whose mutation results in vascular malformations, we have found that it is involve
192 (<1 year), venous or orthopedic surgery, or vascular malformations were clinically stratified for CV
195 rteriovenous malformations (AVMs) are common vascular malformations, which may result in hemorrhagic
196 data from the Scottish Audit of Intracranial Vascular Malformations, which prospectively identified i
197 children aged 6 to 18 years with a slow-flow vascular malformation who were recruited between Septemb
198 tinterventional perfusion changes within the vascular malformation with calculation of changes in con
201 ous malformations (AVMs) are the most common vascular malformations worldwide and the leading cause o
202 tion of hemangiomas (48 of 49) compared with vascular malformations (zero of 38) consisted of a solid